Octaplex

Human Coagulation Factor IX, the active ingredient in Octaplex, is a coagulation factor presented as a sterile injectable solution for intravenous use. It is used to treat and prevent bleeding episodes in patients with hemophilia B and other inherited coagulation factor deficiencies. GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Octaplex is a plasma‑derived coagulation factor concentrate that acts on the intrinsic pathway of the clotting cascade.

- Hemophilia B: provides functional Factor IX to reduce bleeding frequency and severity. - Acquired Factor IX deficiency: replaces missing factor to control hemorrhage. - Peri‑operative management: supports hemostasis during surgery for patients with known factor deficiencies.

Octaplex may cause adverse reactions ranging from mild to severe.

Common Side Effects: - Fever - Headache - Nausea - Mild infusion‑related erythema - Transient increase of ALT enzymes - Mild hypotension

Serious or Rare Side Effects: - Anaphylactic reaction - Thromboembolic events - Severe hypotension - Hemolysis - Development of inhibitors against Factor IX - Acute renal injury

OctPatients may require    Patients   ");

-   t  ",